Assessment of Islet Quality following International Shipping of more than 10,000 km
- 1 June 2010
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 19 (6-7) , 731-741
Abstract
Islet transplantation is an attractive therapy for type 1 diabetes, although some issues remain. One of them is the severe donor shortage in some countries. In this study, we investigated the possibility of international islet shipping beyond 10,000 km to supply islets to countries with donor shortages. Human islets were isolated from six cadaver donors and cultured until shipment. Islets were packed in either gas-permeable bags or in non-gas-permeable bags and shipped from Baylor Research Institute (Dallas, TX, USA) to Fukuoka University (Fukuoka, Japan). Pre- and postshipment islet number, purity, viability, and stimulation index (by glucose stimulation test) were assessed. Shipped 1,500 IE islets were transplanted into streptozotocin-induced diabetic nude mice for in vivo assay. The distance of our shipment was 11,148.4 km, and the mean duration of the shipments was 48.2 ± 8.2 h. The islet number recovery rate (postshipment/preshipment) was significantly higher in gas-permeable bags (56.4 ± 10.1% vs. 20.5 ± 20.6%, p < 0.01). Islet purity was significantly reduced during shipment in non-gas-permeable bags (from 47.7 ± 18.6% to 40.2 ± 28.2 in gas-permeable bags vs. from 50.4 ± 6.4% to 25.9 ± 15.6% in non-gas-permeable bags, p < 0.05). Islet viability and stimulation index did not change significantly between pre- and postshipping, in either gas-permeable bags or in non-gas-permeable bags. One of three diabetic nude mice (33.3%) converted to normoglycemia. It is feasible to ship human islet cells internationally in gas-permeable bags. This strategy would promote basic and preclinical research for countries with donor shortages, even though the research centers are remote (over 10,000 km from the islet isolation center).Keywords
This publication has 21 references indexed in Scilit:
- Estimation of Donor Usability for Islet Transplantation in the United States with the Kyoto Islet Isolation MethodCell Transplantation, 2009
- Islet cell transplantation for the treatment of type 1 diabetes in the USAJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Shipment of Human Islets for TransplantationAmerican Journal of Transplantation, 2007
- Islet Transplantation in Type 1 Diabetes Mellitus Using Cultured Islets and Steroid‐Free Immunosuppression: Miami ExperienceAmerican Journal of Transplantation, 2005
- Successful islet after kidney transplantations in a distance over 1000 kilometres: Preliminary results of the Budapest-Geneva collaborationTransplantation Proceedings, 2004
- Transplantation of Cultured Islets from Two-Layer Preserved Pancreases in Type 1 Diabetes with Anti-CD3 AntibodyAmerican Journal of Transplantation, 2004
- Perfluorocarbon for organ preservation before transplantation1Transplantation, 2002
- Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation centerTransplantation, 2002
- CLINICAL APPLICATION OF THE TWO-LAYER (UNIVERSITY OF WISCONSIN SOLUTION/PERFLUOROCHEMICAL PLUS O 2) METHOD OF PANCREAS PRESERVATION BEFORE TRANSPLANTATIONTransplantation, 2000
- Assessment of islet cell viability using fluorescent dyesDiabetologia, 1987